Two Sigma Advisers’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93M | Sell |
92,700
-48,100
| -34% | -$1.52M | 0.01% | 956 |
|
|
2025
Q1 | $4.67M | Buy |
140,800
+41,900
| +42% | +$1.39M | 0.01% | 815 |
|
|
2024
Q4 | $3.4M | Buy |
98,900
+17,700
| +22% | +$609K | 0.01% | 874 |
|
|
2024
Q3 | $3.25M | Sell |
81,200
-11,500
| -12% | -$460K | 0.01% | 859 |
|
|
2024
Q2 | $2.8M | Sell |
92,700
-59,500
| -39% | -$1.8M | 0.01% | 1014 |
|
|
2024
Q1 | $5.11M | Sell |
152,200
-500
| -0.3% | -$16.8K | 0.01% | 775 |
|
|
2023
Q4 | $4.93M | Sell |
152,700
-139,400
| -48% | -$4.5M | 0.01% | 807 |
|
|
2023
Q3 | $9.57M | Sell |
292,100
-110,700
| -27% | -$3.63M | 0.02% | 484 |
|
|
2023
Q2 | $14.2M | Buy |
402,800
+38,900
| +11% | +$1.37M | 0.04% | 388 |
|
|
2023
Q1 | $11.9M | Sell |
363,900
-56,600
| -13% | -$1.85M | 0.03% | 495 |
|
|
2022
Q4 | $23.2M | Buy |
420,500
+108,600
| +35% | +$5.98M | 0.06% | 299 |
|
|
2022
Q3 | $13.8M | Buy |
311,900
+74,900
| +32% | +$3.32M | 0.04% | 409 |
|
|
2022
Q2 | $11.6M | Buy |
237,000
+70,200
| +42% | +$3.42M | 0.03% | 467 |
|
|
2022
Q1 | $8.12M | Buy |
+166,800
| New | +$8.12M | 0.02% | 601 |
|